Read the latest updates about Igennus Healthcare Nutrition, our people and our products!

Igennus expands its offering to help people lead happier, healthier lives with the launch of personalised nutrition coaching from MyOnlineCLINIC

This week we are excited to launch MyOnlineCLINIC – the UK’s first online personalised nutrition and health programme that guides you towards optimum health with advice that’s relevant and unique to you.  The result of many months of work from our team here at Igennus, we are excited to start […]

The new, upgraded Pharmepa MAINTAIN

Pharmepa MAINTAIN is a new & improved ultra-high potency omega-3 fish oil supplement – offering super-concentrated and absorbable omega-3 in rTG form to increase cellular EPA and DHA levels rapidly, with additional omega-6 GLA for optimum health maintenance. Pharmepa MAINTAIN is the ideal follow-on supplement after taking pure EPA to […]


New Opti-O-3 blood spot biomarker test facilitates personalised nutrition

The new Opti-O-3 blood spot biomarker test from Igennus takes clinical nutrition to the next level through facilitating an evidence-based treatment approach and personalised nutrition for patients. The Opti-O-3 blood spot test includes a fatty acid profile and measures clinically validated biomarkers including the omega-3 index, the omega-6 to omega-3 […]

Igennus Healthcare Nutrition celebrates 10th anniversary

May 2014 is a special time for us here at Igennus Healthcare Nutrition as we mark our 10th anniversary.  Since 2004, we have pioneered therapeutic EPA-only omega-3 formulations, offering effective science-based healthcare solutions for the treatment of inflammatory conditions. As we celebrate our 10th birthday, we’d like to reflect and […]

CAM magazine

For her first invited contribution to CAM magazine, our Head of Clinical Nutrition, Dr Nina Bailey reviewed the latest research on the role of the omega-3s EPA and DHA in the prevention and management of cardiovascular health. Nina clarifies many of the inaccuracies within publications contesting their benefits. Dr Bailey’s […]